Skip to main content
. Author manuscript; available in PMC: 2013 Apr 25.
Published in final edited form as: N Engl J Med. 2012 Oct 25;367(17):1596–1606. doi: 10.1056/NEJMoa1207756

Figure 1. Mortality among Patients with Colorectal Cancer, According to Regular Use or Nonuse of Aspirin after Diagnosis and PIK3CA Mutation Status.

Figure 1

Panels A and B show colorectal cancer–specific mortality among patients with mutant-PIK3CA tumors and those with wild-type PIK3CA tumors, respectively, and Panels C and D show overall mortality in the respective subgroups of patients.